Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection

Abstract

Background and Aims Cirrhosis from hepatitis C virus (HCV) infection is a major cause of end-stage liver disease and hepatocellular carcinoma worldwide. We determine the prevalence of cirrhosis among HCV-infected American adults including those unaware of their infection. Methods Using the National Health and Nutrition Examination Survey (NHANES) data, we identified participants aged≥20 years with detectable serum HCV RNA. The prevalence of advanced fibrosis and cirrhosis was determined for Eras 1 (1988-94), 2 (1999-2006) and 3 (2007-12) by using FIB-4 > 3.25 and APRI > 2.0, respectively. Results Out of 52,644 NHANES examinees, 49,429 were tested for HCV, of whom 725 met the inclusion criteria (positive HCV RNA with available data for FIB-4 and APRI). Based on APRI, 6.6% (95% confidence interval [CI]:2.2-11.0) of HCV-infected adults in Era 1, 7.6% (95%CI:3.4-11.8) in Era 2 and 17.0% (95%CI:8.0-26.0) in Era 3 had cirrhosis. In the multivariable regression analysis, this era effect was attributable to increasing age (odds ratio [OR]:1.04, 95%CI:1.02-1.07), diabetes (OR:2.33, 95%CI:1.01-5.40) and obesity (OR:2.96, 95%CI:1.15-7.57). Cirrhosis was as common among respondents who were unaware of their infection as those who were aware (both 11%). Results were identical when FIB-4 was used. Conclusions Among HCV-infected American adults, the proportion with cirrhosis has increased rapidly. Cirrhosis prevalence remains high in individuals unaware of their HCV infection. These data highlight the urgency for HCV screening regardless of symptoms, systematic assessment for liver fibrosis in those with HCV infection and institution of antivirals to prevent advanced liver disease.

The Relationship between Serum Bilirubin and Elevated Fibrotic Indices among HBV Carriers: A Cross-Sectional Study of a Chinese Population

“…Noninvasive methods had overcome the limitations of liver biopsy and were also used as prognostic indices for subjects with hepatitis B-associated HCC [39]. Furthermore, the accuracy of FIB-4 and APRI were 78% and 76% [40], suggesting they were suitable for regular monitoring of disease progression [41,42]. Thus, using APRI and FIB-4 to assess liver fibrosis was acceptable in the circumstances of the study.…”

Histological assessment of the liver explant in transplanted hepatitis C virus patients achieving sustained virological response with direct‐acting antiviral agents

“…Hepatitis C virus (HCV) is a major cause of chronic liver disease, with an estimated infection rate of 185 million individuals globally . The National Health and Nutrition Examination Survey (2003–2010) reported that ~2.7 million US residents had chronic HCV infection . The recent development of direct‐acting antiviral agents (DAAs) has transformed the management of patients with chronic HCV, and treatments are associated with sustained virological response (SVR) rates of >95% .…”

Recent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota

“…While the prevalence of HCV infection peaked in the early 2000s and has been decreasing in the US 15, 16 , an increasing proportion of HCV patients have advanced stage liver disease. 17 Therefore, the absolute number of HCV patients who remain at high risk for HCC may have increased. Successful HCV eradication has been shown to be associated with an 81% reduction in the risk of HCC development in HCV patients with advanced fibrosis or cirrhosis.…”